Pediatric Behçet's disease and thromboses

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 387-390

  Krupa, Brice ^a   Cimaz, Rolando ^b   Ozen, Seza ^e   Fischbach, Michel ^c   Cochat, Pierre ^b   Koné Paut, Isabelle ^d  

^a Medical University of Dijon   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d BICÊTRE HOSPITAL   (France)

^e HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Children; Thrombophilia; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPARIN; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TINZAPARIN; WARFARIN;

ADOLESCENT; ARTERY THROMBOSIS; ARTICLE; BEHCET DISEASE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CRANIAL SINUS; DISEASE COURSE; DISEASE MARKER; FEMALE; FRANCE; HUMAN; LEG THROMBOSIS; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOPHILIA; VEIN THROMBOSIS; THROMBOSIS;

ADOLESCENT; BEHCET SYNDROME; CHILD; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 79551714035     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100257     Document Type: Article

References (39)

1. Behçet H. Uber rezidivierende aphtöse durch ein virusverursachtes Geschwüre am Mund, am Auge, und an den Genitalien. Dermatol Wochenschr 1938;105:1152-7.
2. Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81-3.
3. Yazici H, Tüzün Y, Pazarli H, Yalçin B, Yurdakul S, Müftüoglu A. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980;7:206-10. (Pubitemid 11222935)
4. International Study Group for Behçet's Disease. Criteria for the diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
5. Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M. Behçet's disease and thrombophilia. Ann Rheum Dis 2001;60:1081-5.
6. Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Esen M, et al. Vascular endothelial function and plasma homocysteine levels in Behçet's disease. Am J Cardiol 2004;94:522-5. (Pubitemid 39120011)
7. Navarro S, Ricart JM, Medina P, Vaya A, Villa P, Todoli J, et al. Activated protein C levels in Behçet's disease and risk of venous thrombosis. Br J Haematol 2004;126:550-6. (Pubitemid 39093098)
8. Tunc SE, Aksu K, Keser G, Oksel F, Doganavsargil E, Pirildar T, et al. Platelet-activating factor and P-selectin activities in thrombotic and non-thrombotic Behçet's patients. Rheumatol Int 2005;25:326-31. (Pubitemid 40922247)
9. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008;58:3951-9.
10. Koné-Paut I, Gorchakoff-Molinas A, Weschler B, Touitou I. Paediatric Behçet's disease in France. Ann Rheum Dis 2002;61:655-6.
11. Pivetti-Pezzi P, Accorinti M, Abdulaziz MA, La Cava M, Torella M, Riso D. Behçet's disease in children. Jpn J Ophthalmol 1995;39:309-14.
12. Koné-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr 1998;132:721-5.
13. Alper G, Yilmaz Y, Ekinci G, Köse Ö. Cerebral vein thrombosis in Behçet's disease: a case report. Pediatr Neurol 2001;25:332-5. (Pubitemid 33028890)
14. Koné-Paut I, Bernard JL. La maladie de Behçet chez l'enfant. Arch Fr Pédiatr 1993;50:145-54.
15. Koné-Paut I, Bernard JL. La maladie de Behçet chez l'enfant en France. Arch Fr Pédiatr 1993;50:561-5.
16. Laghmari M, Karim A, Allali F, Elmadani A, Ibrahimi W, Hajjaj Hassouni N, et al. Childhood Behçet's disease: clinical and evolutive aspects. About 13 cases. J Fr Ophtalmol 2002;25:904-8.
17. Kim DK, Chang SN, Bang D, Lee ES, Lee S. Clinical analysis of 40 cases of childhood-onset Behçet's disease. Pediatr Dermatol 1994;11:95-101. (Pubitemid 24174273)
18. Demirer S, Sengul N, Yardel MA, Tuzuner A, Ulus AT, Gurler A, et al. Haemostasis in patients with Behçet's disease. Eur J Vasc Endovasc Surg 2000;19:570-4.
19. Hampton KK, Chamberlain MA, Nenon DK. Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost 1991;66:292-4.
20. Sengul N, Demirer S, Yerdel MA, Terzioglu G, Akin B, Gurler A, et al. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement. World J Surg 2000;24:1584-8.
21. Oner AF, Gürgey A, Gürler A, Mesci L. Factor V Leiden mutation in patients with Behçet's disease. J Rheumatol 1998;25:496-8.
22. Koné-Paut I, Darce Billo M, Shahram F, Gattorno M, Cimaz R, Ozen S, et al. Pediatric Behçet's disease, PED-BD. An international study of 110 patients. One-year followup data. Rheumatology 2010;[in press].
23. El Menyawi MM, Raslan HM, Edrees A. Clinical features of Behçet's disease in Egypt. Rheumatol Int 2005;29:641-6.
24. Yazici H, Esen F. Mortality in Behçet's syndrome. Clin Exp Rheumatol 2008;26:138-40.
25. Alpsoy E, Dommez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol 2007;157:901-6.
26. Saadoun D, Wechsler B, Resche-Rigon M, Trad S, Le Thi Huong D, Sbai A, et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum 2009;61:518-26.
27. Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS. Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008;27:405-6.
28. Ozen S, Bilginer Y, Besbas N, Ayaz NA, Bakkaloglu A. Behçet disease: treatment of vascular involvement in children. Eur J Pediatr 2010;169:427-30.
29. Mader R, Ziv M, Adawi M, Mader R, Lavi I. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol 1999;26:2404-8.
30. Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia 2008;14:1214-21.
31. Albisetti M, Moeller A, Waldvogel K, Bernet-Buettiker V, Cannizzaro V, Anagnostopoulos A, et al. Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses. Acta Haematol 2007;117:149-55.
32. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, et al. MEFV mutations in Behçet's disease. Hum Mutat 2000;16:271-2.
33. Imirzalioglu N, Dursun A, Tastan B, Soysal Y, Yakicier MC. MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 2005;34:56-8.
34. Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A. Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 2007;36:48-52. (Pubitemid 46572912)
35. Ataqunduz P, Erqun T, Direskeneli H. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003;21:35-7.
36. Atkinson M, Moore E, Altinok D, Acsadi G. Cerebral infarct in paediatric neuro-Behçet's disease. J Child Neurol 2008;23:1331-5.
37. Budin C, Ranchin B, Glastre C, Fouilhoux A, Canterino I, David L. Neurologic signs revealing a Behçet's disease: two pediatric case reports. Arch Pediatr 2002;9:1160-2.
38. Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, et al. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behçet's syndrome. Rheumatology 2007;46:1213-4.
39. Besbas N, Ozyürek E, Balkanci F, Ozen S, Saatci I, Ozatlin F, et al. Behçet's disease with severe arterial involvement in a child. Clin Rheumatol 2002;21:176-9. (Pubitemid 34649603)